VISTASEAL
As listed in the register: VISTASEAL
160 mg + 1000 unit · solution
- Prescription status not stated
- Blood, clotting and anaemia
- Active substance
- Fibrinogen (Human) + Thrombin (Human)
- Used in
- Blood, clotting and anaemia
- Made by
- Instituto Grifols S.a.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Details
| Made by | Instituto Grifols S.a. |
|---|---|
| Active substance | Fibrinogen (Human) + Thrombin (Human) |
| Used in | Blood, clotting and anaemia |
| Strength | 160 mg + 1000 unit |
| Form | solution |
| Classification | B02BD30 · Blood, clotting and anaemia |
| Route | topical |
| Dispensing (as stated by the register) | SCHEDULE D |
| Status | Marketed |
| Marketed | Yes, according to the register |
| DIN | 02514230 |
| DPD drug code | 100340 |
Source: Drug Product Database · 2026-09-30 · not reviewed by a clinician
Contains information licensed under the Open Government Licence – Canada. Reuse terms: Open Government Licence – Canada.
Other strengths and forms
4 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- solution4 products
- 80 mg + 500 unit
- 160 mg + 1000 unit
- 240 mg + 1500 unit
- 400 mg + 2500 unit
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.
See every product with Fibrinogen (Human) + Thrombin (Human)